iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Jubilant Generics three products removed from USFDAs excepted products list

19 Jul 2022 , 01:34 AM

Jubilant Pharmovas wholly owned subsidiary Jubilant Pharma Limited today announced that its subsidiary Jubilant Generics JGL received a communication from the USFDA through which the latter intimated that it has decided to remove olanzapine orally disintegrating tablets spironolactone tablets and valsartan tablets from the list of excepted products from the Import Alert at the Roorkee facility of JGL The USFDA mentioned its review of the product supply situation in the market and companys compliance status as the reasons for this decision The current revenue from these three products is less than 1Percentage of the consolidated revenues of the Company Post this currently only Risperidone orally disintegrating tablets are allowed for import into the US from the Roorkee facility

Related Tags

  • Announcements
  • BSE
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.